Atmika Paul: How SMAD4 Loss Drives Chromosomal Instability in Cancer
Atmika Paul/LinkedIn

Atmika Paul: How SMAD4 Loss Drives Chromosomal Instability in Cancer

Atmika Paul, Postdoctoral Researcher at Universitätsmedizin Göttingen, shared on LinkedIn:

“Thought p53 was the only guardian of our genome? Meet another: SMAD4.

Excited to share that our work from Universitätsmedizin Göttingen is finally published in Science Advances!

We uncover a previously unrecognized role for SMAD4 in safeguarding genome integrity, revealing how its loss drives both structural and numerical chromosomal instability (CIN) in human cancers.

  • When transcription clashes with replication: SMAD4 loss promotes head-on collisions between transcription and replication machineries (TRCs), triggering replication stress.
  • Beyond TGF-β: Unexpectedly, the genome-protective function of SMAD4 relies on BMP–SMAD4 signaling, a pathway better known for its roles in early development.
  • The key effector, ID3: SMAD4 loss downregulates ID3, a transcriptional target of BMP–SMAD4 signaling. This impedes RAD51 recruitment at DNA damage sites, thus impairing homologous recombination (HR).
  • From replication stress to CIN: Together, defective DNA repair and replication stress lead to chromosome breaks and mitotic segregation errors, driving persistent structural chromosomal aberrations and aneuploidy in cancers.
  • A therapeutic vulnerability: Loss of SMAD4 creates HR deficiency and this sensitizes cancer cells to platinum-based therapies in our experimental models.

With SMAD4 expression lost in approximately 60% of pancreatic cancers and 20% of colorectal cancers, our findings reveal a previously underappreciated route to chromosomal instability and highlight the importance of uncovering new regulators of genome integrity.

Grateful to our wonderful collaborators and coauthors who made this work possible!”

Title: SMAD4 loss drives cancer chromosomal instability through transcription-replication conflict–associated replication stress

Authors: Atmika Paul, Gargee Joshi, Philipp Jungk, Simranjeet Kaur, Shengyu Yao, Ioannis Tsirkas, Nicolas Böhly, Maren Sitte, Gabriela Salinas, Stephan Hamperl, Maik Kschischo, Holger Bastians.

Read the full article.

You can also read:

Joshua Schiffman: Translating Elephant p53’s Cancer-Fighting Biology Into Potential New Treatments